Linagliptin alleviates fatty liver disease in diabetic db/db mice

Figure 8 The distribution of hepatocytes with lipid inclusions depending on the size of lipid droplets in linagliptin-treated and placebo-treated db/db mice. The reduction in the numeral density of hepatocytes with microsized, mediosized and macrosized droplets in linagliptin-treated mice (hep, hepatocyte, ^aP < 0.05 vs placebo group).